Author

Max N Quastel

University of Oxford

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Christina HeroveniD· 1 shared Adán Pinto-FernándeziD· 1 shared Alexander Greenshields‐WatsoniD· 1 shared Charlotte Mary DeaneiD· 1 shared Christopher J. ThorpeiD· 1 shared Dan Hudson· 1 shared Gillespie· 1 shared Julia V McCarthy· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Christina HerovenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Reverse engineering the fatally cross-reactive A3A TCR to decouple potency and specificity

Julia V McCarthy, A. Christina Heroven, King Ifashe, Martin Fellermeyer, Dan Hudson, Raul Cioaca, Max N Quastel, Yunkai Yang, Matteo Cagiada, Simeon D. Dragonov, Christopher J. Thorpe, Adán Pinto-Fernández, Alexander Greenshields‐Watson, Gillespie, Charlotte Mary Deane, Ricardo A. Fernandes

The paper reverse-engineers a TCR to reduce cross-reactivity while maintaining potency by reverting specific residues.

bioRxiv · May 6, 2026 · PreprintImmunology